PANGAEA Oncology Logo

PANGAEA Oncology

Precision oncology services in diagnostics and R&D for patients and the pharmaceutical industry.

PANG | BME Growth

Overview

Corporate Details

ISIN(s):
ES0105221008
LEI:
959800TSRNQZYHX37Y29
Country:
Spain
Address:
C/ COSO 42 4º, 50004 Zaragoza
Sector:
Human health and social work activities
Industry:
Other human health activities

Description

PANGAEA Oncology is a medical services company specializing in precision oncology, dedicated to improving the survival and quality of life for cancer patients. Founded in 2007, the company provides services to both patients and the pharmaceutical industry. Its offerings include advanced molecular diagnostics, validation for companion diagnostic (Dx) platforms, and a range of preclinical R&D services such as biomarker discovery, in-vitro testing, and organoid technology. A key innovator, PANGAEA was the first laboratory in Spain to be accredited for liquid biopsy techniques. By operating directly within hospital settings, the company accelerates clinical trials by providing direct access to patients, samples, and clinical data, positioning itself as a leading recruitment center. PANGAEA leverages genetic analyses and data-driven approaches to advance personalized cancer treatment and research.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all PANGAEA Oncology filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PANGAEA Oncology

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PANGAEA Oncology via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

LABCORP HOLDINGS INC. Logo
Provides diagnostic lab testing and biopharma drug development services for healthcare clients.
United States of America
LH
LabGenomics. Co., Ltd. Logo
Provider of NGS-based molecular diagnostics for prenatal, cancer, and direct-to-consumer testing.
South Korea
084650
Lucid Diagnostics Inc. Logo
Offers a non-invasive DNA test for early detection of esophageal precancer in at-risk patients.
United States of America
LUCD
Develops AI-enhanced blood tests to evaluate indeterminate lung nodules for early cancer detection.
United States of America
LLAI
MDxHealth SA Logo
Advanced molecular diagnostics for urologic diseases, focusing on personalized prostate cancer care.
Belgium
MDXH
Medical Ikkou Group Co.,Ltd. Logo
Operates dispensing pharmacies and manages residential nursing and long-term care facilities.
Japan
3353
Medirom Healthcare Technologies Inc. Logo
Operates relaxation salons integrating hands-on wellness with digital health technology.
United States of America
MRM
METACARE Co., Ltd. Logo
South Korea
118000
Metrics in Balance N.V. Logo
Develops posture clinics, dental splints & DNA tests for European consumers & professionals.
Belgium
MLMIB
MONA YONGPYONG CO.,LTD  Logo
Operates a comprehensive South Korean resort with year-round ski, golf, and leisure facilities.
South Korea
070960

Talk to a Data Expert

Have a question? We'll get back to you promptly.